NASDAQ:PTC

PTC News Headlines

$146.66
+0.62 (+0.42 %)
(As of 04/12/2021 02:07 PM ET)
Add
Compare
Today's Range
$144.67
Now: $146.66
$147.11
50-Day Range
$118.85
MA: $135.54
$146.73
52-Week Range
$60.98
Now: $146.66
$149.26
Volume5,544 shs
Average Volume765,531 shs
Market Capitalization$17.13 billion
P/E Ratio129.79
Dividend YieldN/A
Beta1.33

Headlines

PTC (NASDAQ PTC) News Headlines Today

SourceHeadline
IJH, TECH, PTC, CGNX: Large Inflows Detected at ETF - NasdaqIJH, TECH, PTC, CGNX: Large Inflows Detected at ETF - Nasdaq
nasdaq.com - April 12 at 11:28 AM
PTC to Announce Fiscal Q221 Results on Wednesday, April 28th, 2021PTC to Announce Fiscal Q2'21 Results on Wednesday, April 28th, 2021
finance.yahoo.com - April 12 at 11:28 AM
PTC Stock Gives Every Indication Of Being Significantly Overvalued - Yahoo FinancePTC Stock Gives Every Indication Of Being Significantly Overvalued - Yahoo Finance
finance.yahoo.com - April 11 at 10:31 PM
PTC Inc. (NASDAQ:PTC) Receives Consensus Recommendation of "Buy" from AnalystsPTC Inc. (NASDAQ:PTC) Receives Consensus Recommendation of "Buy" from Analysts
americanbankingnews.com - April 10 at 9:00 AM
3 Software Stocks to Buy for the Coming Infrastructure Spending Boom - Motley Fool3 Software Stocks to Buy for the Coming Infrastructure Spending Boom - Motley Fool
fool.com - April 10 at 8:24 AM
PTC Closes In On Buy Point - Yahoo FinancePTC Closes In On Buy Point - Yahoo Finance
finance.yahoo.com - April 9 at 7:55 AM
PTC, IBD Stock Of The Day, Flirts With Buy Zone Ahead Of Earnings Report - Investors Business DailyPTC, IBD Stock Of The Day, Flirts With Buy Zone Ahead Of Earnings Report - Investor's Business Daily
investors.com - April 8 at 7:48 PM
PTC Closes In On Buy PointPTC Closes In On Buy Point
finance.yahoo.com - April 8 at 7:48 PM
PTC Therapeutics Received Gallups "Don Clifton Strengths-Based Culture" Award - StreetInsider.comPTC Therapeutics Received Gallup's "Don Clifton Strengths-Based Culture" Award - StreetInsider.com
streetinsider.com - April 8 at 2:47 PM
PTC (NASDAQ:PTC) Reaches New 1-Year High at $149.08PTC (NASDAQ:PTC) Reaches New 1-Year High at $149.08
americanbankingnews.com - April 8 at 10:46 AM
Did The Underlying Business Drive PTCs (NASDAQ:PTC) Lovely 347% Share Price Gain? - Yahoo FinanceDid The Underlying Business Drive PTC's (NASDAQ:PTC) Lovely 347% Share Price Gain? - Yahoo Finance
finance.yahoo.com - April 7 at 11:09 PM
Did The Underlying Business Drive PTCs (NASDAQ:PTC) Lovely 347% Share Price Gain?Did The Underlying Business Drive PTC's (NASDAQ:PTC) Lovely 347% Share Price Gain?
finance.yahoo.com - April 7 at 6:08 PM
PTC Strength Rating Jumps To 83: Stocks To Watch - Investors Business DailyPTC Strength Rating Jumps To 83: Stocks To Watch - Investor's Business Daily
investors.com - April 5 at 6:20 PM
IBD 50 Stock To Watch PTC, A 5G Smart Factory Play, Rallies Toward Its Buy Point - Investors Business DailyIBD 50 Stock To Watch PTC, A 5G Smart Factory Play, Rallies Toward Its Buy Point - Investor's Business Daily
investors.com - April 5 at 6:20 PM
IBD 50 Stock To Watch PTC, A 5G Smart Factory Play, Rallies Toward Its Buy PointIBD 50 Stock To Watch PTC, A 5G Smart Factory Play, Rallies Toward Its Buy Point
finance.yahoo.com - April 5 at 6:20 PM
Stocks To Watch: PTC Sees RS Rating Rise To 83 - Investors Business DailyStocks To Watch: PTC Sees RS Rating Rise To 83 - Investor's Business Daily
investors.com - April 5 at 1:19 PM
Notice Regarding Acquisition of Shares in PTC SYSTEM (S) PTE LTD (as a New Subsidiary) - Yahoo FinanceNotice Regarding Acquisition of Shares in PTC SYSTEM (S) PTE LTD (as a New Subsidiary) - Yahoo Finance
finance.yahoo.com - April 1 at 8:56 AM
WABAG secures financial closure of its second HAM project; partners with PTC India Financial ServicesWABAG secures financial closure of its second HAM project; partners with PTC India Financial Services
msn.com - March 31 at 4:35 AM
PTC Therapeutics : EC Approves Evrysdi To Treat Spinal Muscular Atrophy - NasdaqPTC Therapeutics : EC Approves Evrysdi To Treat Spinal Muscular Atrophy - Nasdaq
nasdaq.com - March 30 at 11:34 PM
PTC Therapeutics : EC Approves Evrysdi To Treat Spinal Muscular AtrophyPTC Therapeutics : EC Approves Evrysdi To Treat Spinal Muscular Atrophy
markets.businessinsider.com - March 30 at 3:32 AM
PTC Therapeutics upgraded to sector perform at RBC - Seeking AlphaPTC Therapeutics upgraded to sector perform at RBC - Seeking Alpha
seekingalpha.com - March 29 at 12:29 PM
Is PTC Stock A Buy or Sell? - Yahoo FinanceIs PTC Stock A Buy or Sell? - Yahoo Finance
finance.yahoo.com - March 29 at 12:29 PM
PTC Expands Spatial Computing Capabilities with Vuforia Engine Area TargetsPTC Expands Spatial Computing Capabilities with Vuforia Engine Area Targets
finance.yahoo.com - March 29 at 12:29 PM
Is PTC Stock A Buy or Sell?Is PTC Stock A Buy or Sell?
finance.yahoo.com - March 29 at 12:29 PM
The Recent Sell-Off Is a Buying Opportunity for This Unstoppable Stock - Motley FoolThe Recent Sell-Off Is a Buying Opportunity for This Unstoppable Stock - Motley Fool
fool.com - March 26 at 8:46 AM
$418.46 Million in Sales Expected for PTC Inc. (NASDAQ:PTC) This Quarter$418.46 Million in Sales Expected for PTC Inc. (NASDAQ:PTC) This Quarter
americanbankingnews.com - March 21 at 5:16 AM
PTC Inc. -- Moodys announces completion of a periodic review of ratings of PTC Inc. - Yahoo FinancePTC Inc. -- Moody's announces completion of a periodic review of ratings of PTC Inc. - Yahoo Finance
finance.yahoo.com - March 17 at 7:18 PM
PTC: A Story With Many Components, Not All Of Them Well Recognized - Seeking AlphaPTC: A Story With Many Components, Not All Of Them Well Recognized - Seeking Alpha
seekingalpha.com - March 17 at 7:18 PM
PTC study shows long-term benefit of spinal muscular atrophy therapy - Seeking AlphaPTC study shows long-term benefit of spinal muscular atrophy therapy - Seeking Alpha
seekingalpha.com - March 16 at 7:02 PM
MDY, CGNX, PTC, FICO: ETF Outflow Alert - NasdaqMDY, CGNX, PTC, FICO: ETF Outflow Alert - Nasdaq
nasdaq.com - March 16 at 7:02 PM
PTC India Financial Services sanctions nearly Rs 1,000 cr to diversified projectsPTC India Financial Services sanctions nearly Rs 1,000 cr to diversified projects
in.finance.yahoo.com - March 16 at 2:02 PM
PTC Reaches Analyst Target PricePTC Reaches Analyst Target Price
nasdaq.com - March 11 at 5:43 PM
PTC India Financial Services Ltd leads losers in A groupPTC India Financial Services Ltd leads losers in 'A' group
in.finance.yahoo.com - March 5 at 1:27 PM
3 Top Growth Stocks to Buy in March - Motley Fool3 Top Growth Stocks to Buy in March - Motley Fool
fool.com - March 4 at 3:36 PM
Premium Tax Credit 2021 Definition - InvestopediaPremium Tax Credit 2021 Definition - Investopedia
investopedia.com - March 4 at 12:00 AM
Notable ETF Outflow Detected - MDYG, PTC, TECH, CGNXNotable ETF Outflow Detected - MDYG, PTC, TECH, CGNX
nasdaq.com - March 3 at 8:58 AM
Should You Think About Buying PTC Inc. (NASDAQ:PTC) Now? - Yahoo FinanceShould You Think About Buying PTC Inc. (NASDAQ:PTC) Now? - Yahoo Finance
finance.yahoo.com - March 2 at 2:10 PM
Should You Think About Buying PTC Inc. (NASDAQ:PTC) Now?Should You Think About Buying PTC Inc. (NASDAQ:PTC) Now?
finance.yahoo.com - March 2 at 2:10 PM
Top-Rated Stocks: PTC Designs Surges - Investors Business DailyTop-Rated Stocks: PTC Designs Surges - Investor's Business Daily
investors.com - March 1 at 6:51 PM
EMA backs PTC Therapeutics Evrysdi for spinal muscular atrophy - Seeking AlphaEMA backs PTC Therapeutics' Evrysdi for spinal muscular atrophy - Seeking Alpha
seekingalpha.com - February 26 at 11:42 PM
PTC Therapeutics (PTCT) Misses Q4 EPS by 14c, Revenues Beat - StreetInsider.comPTC Therapeutics (PTCT) Misses Q4 EPS by 14c, Revenues Beat - StreetInsider.com
streetinsider.com - February 26 at 8:03 AM
PTC Therapeutics, Inc (PTCT) CEO Stuart Peltz on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaPTC Therapeutics, Inc (PTCT) CEO Stuart Peltz on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 26 at 3:02 AM
PTC Therapeutics EPS misses by $0.15, beats on revenue - Seeking AlphaPTC Therapeutics EPS misses by $0.15, beats on revenue - Seeking Alpha
seekingalpha.com - February 25 at 10:01 PM
PTC Therapeutics (PTCT) Reports Q4 Loss, Tops Revenue Estimates - NasdaqPTC Therapeutics (PTCT) Reports Q4 Loss, Tops Revenue Estimates - Nasdaq
nasdaq.com - February 25 at 10:01 PM
PTC Therapeutics is Now Oversold (PTCT) - NasdaqPTC Therapeutics is Now Oversold (PTCT) - Nasdaq
nasdaq.com - February 25 at 5:01 PM
PTC Therapeutics, Inc. to Host Earnings Call - Yahoo FinancePTC Therapeutics, Inc. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - February 25 at 5:01 PM
PTC Therapeutics (PTCT) Positive Data from FIREFISH Study of Evrysdi in Infants with Type 1 SMA Published in NEJM - StreetInsider.comPTC Therapeutics (PTCT) Positive Data from FIREFISH Study of Evrysdi in Infants with Type 1 SMA Published in NEJM - StreetInsider.com
streetinsider.com - February 25 at 12:00 PM
PTC Therapeutics Q4 2020 Earnings Preview - Seeking AlphaPTC Therapeutics Q4 2020 Earnings Preview - Seeking Alpha
seekingalpha.com - February 24 at 8:57 PM
Tech exec insights: PTCs Hirschtick on entrepreneurship and agility - Boston Business Journal - Boston Business JournalTech exec insights: PTC's Hirschtick on entrepreneurship and agility - Boston Business Journal - Boston Business Journal
bizjournals.com - February 19 at 6:08 PM
Worldwide IoT Device Management Industry to 2026 - Featuring Microsoft, PTC Incorporation & Telit Communications Among Others - ResearchAndMarkets.com - Business WireWorldwide IoT Device Management Industry to 2026 - Featuring Microsoft, PTC Incorporation & Telit Communications Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - February 18 at 7:52 PM
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.